top of page

Pharma Industry Readies for Drug Pricing Lawsuit Second Wave

Oct 23, 2023

Major drug companies are likely to ratchet up a sprawling legal attack aimed at challenging the Biden administration’s Medicare drug pricing negotiation process, a top pharmaceutical lobby leader told Bloomberg Law.


We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

Privacy

Terms of Use

bottom of page